BRVE vs KRSA: stock comparison and AI forecast
Braveheart Bio, Inc. (BRVE) and Korsana Biosciences, Inc. (KRSA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BRVE Braveheart Bio, Inc.
- Market Cap
- $1.42B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
KRSA Korsana Biosciences, Inc.
- Market Cap
- $1.39B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BRVE and KRSA have similar market capitalizations ($1.42B and $1.39B).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BRVE | KRSA |
|---|---|---|
| Market Cap | $1.42B | $1.39B |
| P/B Ratio | – | 3.55x |
| EPS | – | $-4.95 |
| Book Value/Share | – | $8.57 |
Profitability & Margins
| Metric | BRVE | KRSA |
|---|---|---|
| ROIC | – | -1.2% |
| Operating Margin | – | -248.8% |
| EBT Margin | – | -178.3% |
Financial Health
| Metric | BRVE | KRSA |
|---|---|---|
| Current Ratio | 13.63x | 10.42x |
| D/E Ratio | – | 0.12x |
| Financial Leverage | – | 1.18x |
| Working Capital | $114M | $416M |
Cash Flow
| Metric | BRVE | KRSA |
|---|---|---|
| Operating Cash Flow | – | -$52M |
Income Statement
| Metric | BRVE | KRSA |
|---|---|---|
| Operating Income | – | -$5M |
| R&D Expense | – | $2M |
Dividend & Shareholder Information
| Metric | BRVE | KRSA |
|---|---|---|
| Shares Outstanding | 82M | 46M |
BRVE vs KRSA: stock comparison and AI forecast
Which is bigger, BRVE or KRSA?
BRVE and KRSA have similar market capitalizations ($1.42B and $1.39B).
Which one does Intratio's AI model rank higher, BRVE or KRSA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.